| ID: | 110 | |
|---|---|---|
| Name: | Compound 110 | |
| Description: | Original numeration in publication: A-1 | |
| Labels: | Training_set, Nicotinamide-pyridine | |
| CAS: | ||
| InChi Code: | InChI=1S/C20H17N5O2/c1-14(24-25-20(27)17-5-3-11-22-13-17)15-6-8-18(9-7-15)23-19(26)16-4-2-10-21-12-16/h2-13H,1H3,(H,23,26)(H,25,27)/b24-14+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.66 |
Yousef, R. G.; Ibrahim, A.; Khalifa, M. M. a. E., W. M.; Gobaara, I. M. M.; Mehany, A. B. M. a. E., E. B.; Alsfouk, A. A.; Metwaly, A. M. a. E., I. H. Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. J. Enzyme Inhib. Med. Chem. 2022, 37, 1389–1403. https://doi.org/10.1080/14756366.2022.2070744 |
| 7.48412 |
Eq1: VEGFR-2 inhibition (Data used to train model) |